Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Primex Obtains Article 13 Health Claim for Chitosan - Nutraceuticals World

What are you searching for?

Sign in
Regulations

Primex Obtains Article 13 Health Claim for Chitosan

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Iceland-based Primex has obtained approval from the European Food Safety Authority (EFSA) for an Article 13 health claim relating to its chitosan ingredient and maintenance of normal blood LDL-cholesterol. Based on submitted data, a scientific panel concluded that a cause and effect relationship has been established between the consumption of chitosan and maintenance of normal blood LDL-cholesterol concentrations. The panel considered that in order to obtain the claimed effect, 3 grams of chitosan should be consumed daily. The target population is adults.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters